Study: NCT03509012

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV (intravenous)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV (intravenous)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV (intravenous)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV (intravenous)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV (intravenous)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV (intravenous)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV (intravenous)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV (intravenous)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tremelimumab
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tremelimumab
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin (dose level 4)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin (dose level 3)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin (dose level 3)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin (dose level 3)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin (dose level 3)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin (dose level 1)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide (dose level 1)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide (dose level 2)
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: IV

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External beam radiation (dose level 1)
Description: radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External beam radiation (dose level 2)
Description: radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External beam radiation (dose level 2)
Description: radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External beam radiation (dose level 2)
Description: radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External beam radiation (hyperfractionated)
Description: radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External beam radiation (hyperfractionated)
Description: radiation therapy